Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

The summarized guidelines update the 2014 recommendations for the management of AD with phototherapy and systemic therapies.

A multidisciplinary workgroup conducted a systematic review and applied the GRADE approach for assessing the certainty of the evidence and formulating and grading recommendations.

The workgroup developed 11 recommendations on the management of AD in adults with phototherapy and systemic therapies, including biologics, oral Janus Kinase inhibitors, and other immunomodulatory medications.

The evidence supported strong recommendations for the use of dupilumab, tralokinumab, abrocitinib, baricitinib, and upadacitinib and conditional recommendations in favor of using phototherapy, azathioprine, cyclosporine, methotrexate, and mycophenolate, and against the use of systemic corticosteroids.

Published by Journal of the American Academy of Dermatology, 2024. The guideline itself is at the source linked here.

doi.org/10.1016/j.jaad.2023.08.103